More tools:Markets·Screener·Research·Chat

ICU Medical Inc (ICUI) Financial Statements

ICU Medical Inc
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001S712B3
XNAS · usd
160.89▼ 6.69 (-3.99%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close167.58
Day's Range160.06 – 166.59
52-Week Range112.50 – 192.85
Volume311.1K
Avg Volume296.7K
Share Statistics
Shares Outstanding
Employees13.0K
ExchangeXNAS
Listed1992-03-31
Share count as of July 31, 2026
Loading Income Statement…
Key questions about ICU Medical Inc (ICUI)
What is ICU Medical Inc's Market Cap?
ICU Medical Inc's Market Cap is $4.0B, based on as-reported figures from SEC (XBRL) filings.
What is ICU Medical Inc's Enterprise Value?
ICU Medical Inc's Enterprise Value is $5.0B, based on as-reported figures from SEC (XBRL) filings.
What is ICU Medical Inc's Trailing P/E?
ICU Medical Inc's Trailing P/E is 5496.4×, based on as-reported figures from SEC (XBRL) filings.
What is ICU Medical Inc's Price / Sales?
ICU Medical Inc's Price / Sales is 1.9×, based on as-reported figures from SEC (XBRL) filings.
What is ICU Medical Inc's EV / Revenue?
ICU Medical Inc's EV / Revenue is 2.3×, based on as-reported figures from SEC (XBRL) filings.
What is ICU Medical Inc's EV / EBITDA?
ICU Medical Inc's EV / EBITDA is 18.8×, based on as-reported figures from SEC (XBRL) filings.
What is ICU Medical Inc's Revenue (TTM)?
ICU Medical Inc's Revenue (TTM) is $2.2B, based on as-reported figures from SEC (XBRL) filings.
What is ICU Medical Inc's Net Income (TTM)?
ICU Medical Inc's Net Income (TTM) is $732.0K, based on as-reported figures from SEC (XBRL) filings.
What is ICU Medical Inc's EBITDA?
ICU Medical Inc's EBITDA is $273.3M, based on as-reported figures from SEC (XBRL) filings.
What is ICU Medical Inc's Diluted EPS (TTM)?
ICU Medical Inc's Diluted EPS (TTM) is 0.03, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
REVENUES:
TOTAL REVENUES—
YoY growth+0.5%-12.3%—-8.9%
Cost of goods sold
Gross Profit
% of revenue42.6%38.9%—37.4%
OPERATING EXPENSES:
Selling, general and administrative
Research and development
Restructuring, strategic transaction and integration—
TOTAL OPERATING EXPENSES
% of revenue35.5%36.3%—34.9%
INCOME (LOSS) FROM OPERATIONS
% of revenue7.1%2.6%—2.6%
Interest Expense,net—
OTHER INCOME (EXPENSE), net
Gain on sale of business—
Income (loss0 before income taxes and equity in earnings of unconsolidated affiliates—
PROVISION FOR INCOME TAXES
NET INCOME (LOSS) FROM CONSOLIDATED COMPANIES—
NET INCOME (LOSS)
% of revenue3.5%5.7%—-0.6%
Basic (in dollars per share)
Diluted (in dollars per share)